Phase III randomized trial of doxorubicin + cisplatin versus doxorubicin + 24-h paclitaxel + filgrastim in endometrial carcinoma: a Gynecologic Oncology Group study. - Fleming,G.F.; Filiaci,V.L.; Bentley,R.C.; Herzog,T.; Sorosky,J.; Vaccarello,L.; Gallion,H. (Ann Oncol, 2004)